Barely Significant
← all excerpts

Roles of Goserelin in Gynecological Disorders.

Drug Des Devel Ther · 2026 · PMC13222611 · PMID 42226753

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
100 When assessed at 3 months and 1 year after endometrial resection, patients who had received preoperative goserelin showed a trend of better bleeding control in terms of blood loss-assessment chart scores and the proportions with amenorrhea or scanty bleeding, an effect enhanced by the addition of a post-operative dose of goserelin. 100 , 101 A multi-national prospective, randomized, double-blind study reported that 3 years af

also in 53,322 other papers

highly significantno p-value reported
23 In a prospective study conducted in 28 centers from four Scandinavian countries, patients with symptomatic endometriosis treated with 6-month goserelin (n=113) showed a highly significant reduction of 45% in total pain score, with the prevalence of pelvic tenderness on palpation and pelvic induration reduced by 49% and 41%, respectively. 24 In line with the recent ESHRE recommendation for postoperative hormonal therapy to enhance the immediate pain-relief outcome, a randomized contr

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.